Objectives. Extracorporeal Life Support (ECLS) is an emerging option to treat selected patients with cardiac arrest refractory to cardiopulmonary resuscitation (CPR). Our primary objective was to determine the mortality at 30 days and at hospital discharge among adult patients receiving veno-arterial ECLS for refractory cardiac arrest. Our secondary objectives were to determine the one-year survival and the health-related quality-of-life, and to examine factors associated with 30-days mortality.
Introduction
Extracorporeal Life Support (ECLS) therapy is an option for severe cardiac or cardiopulmonary failure. ECLS consists in an extracorporeal circulation circuit equipped with a rotary blood pump and a blood hollow-fiber oxygenator. There is cumulating evidence over the usefulness of ECLS in improving the survival of selected patients with cardiac arrest refractory to advanced cardiopulmonary resuscitation [1] (E-CPR). The survival at 30 days after ECLS implantation in such patients reportedly ranges between 24% and 36% [2, 3, 4] . Other series have reported survival rates up to 50%. Nonetheless, these studies are difficultly comparable to ours since they included also patients who received ECLS implantation not during cardiopulmonary resuscitation (CPR), or in-hospital cardiac arrest cases only [5] . Nonetheless, there are few evidence available over the clinical outcomes after hospital discharge of patients who survived refractory cardiac arrest and failed CPR thanks to ECLS therapy. This population consists of critically ill patients with major rates of severe in-hospital complications. Therefore, not only the vital status of these patients late after hospital discharge needs to be clarified, but also their quality of life. The latter information are lacking even from the analysis of major multicentre registries [6] , despite they may be important in clinical decision-making and allocation of resources.
Projected quality of life is evidenced in the recent European guidelines as one foremost aspect to be considered while evaluating the indication to ECLS in acute heart failure [6] .
However, such judgment poses major difficulties among patients with refractory cardiogenic shock due to emergent presentation, frequent uncertainty of the extent of brain damage, and coexistence of comorbidities. The literature lacks specific information over this issue as well.
The purpose of the present investigation was twofold. The first objective was to clarify the mortality at 30 days and at hospital discharge in adult patients receiving veno-arterial M A N U S C R I P T
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ECLS for refractory cardiac arrest (E-CPR). The secondary objective was to clarify the one-year survival and the perceived health-related quality-of-life in these patients, and to identify factors associated with 30-day mortality.
Patients and Methods

Patients' selection and technique of ECLS implantation.
Between January 2005 and October 2013, 270 patients received veno-arterial ECLS at our Institution. Of these, 49 (18.1%) were treated on an emergent basis for cardiac arrest refractory to conventional CPR. All the patients included in the present study received ECLS implantation during ongoing CPR. We excluded the patients who had ECLS in the immediate post-cardiotomy circumstances due to the impossibility to wean from cardiopulmonary bypass, and the patients receiving veno-venous ECLS for primary lung dysfunction. No patient received E-CPR out-of-hospital; nevertheless, some patients who suffered cardiac arrest out-of-hospital and received E-CPR within our center were included (N=6, 12%). The cases satisfying the above criteria were retrospectively selected from our database and served for subsequent analyses.
The indications to E-CPR were established in compliance with the current recommendations [6] by a multidisciplinary team including at least one surgeon and two physicians. We adopted the algorithm proposed by Combes and associates [7] . Briefly, E-CPR was contraindicated in case of no-flow time exceeding 5 minutes or unwitnessed cardiac arrest, in case of total expected duration of low-flow exceeding 100 minutes, in case of end-expiratory CO 2 concentration lower than 10 mmHg or of asystole on ECG.
The indication to E-CPR was discussed also in perspective with the patient's known comorbidities and life expectancy. The notion of intoxication or hypothermia ( 32°C) M A N U S C R I P T
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represented an element in favor of the indication to E-CPR during enrollment of the present series. The implanting team included two surgeons (senior and resident), a scrubnurse and a perfusionist. All material is available on a dedicated trailer, allowing full autonomy for prompt displacement of the team within the hospital facilities. Implantation of E-CPR was performed through longitudinal skin incision at the right groin and preparation of the anterior face of the common femoral artery and vein. The femoral vessels were neither encircled nor clamped. The percutaneous technique was never employed, in order to facilitate rapid institution of E-CPR and avoid the difficulties to appreciate pulses and backflow due to marginal hemodynamic conditions. Cannulation was performed using the Seldinger technique; arterial inflow was obtained through a 16 to 20 Fr cannula (Edwards Lifesciences Inc., Irvine, CA), and venous drainage was achieved with an 18 to 24 Fr cannula (Edwards Lifesciences Inc., Irvine, CA). In event of failed cannulation due to extensive arterial calcifications or impossibility to adequately advance the guidewires, the left groin was explored. Distal perfusion of the lower limb was assured through the superficial femoral artery using a 6-to-10 Fr cannula (Seldinger technique) connected to a side branch of the arterial inflow line. During ECLS therapy, heparin was administered through a central venous line in order to maintain an activated clotting time between 150 and 180s; in the presence of hemorrhagic complications, the dose of heparin was adjusted or the administration was temporary withheld. Efficacy of ECLS therapy was monitored by periodical assessment of arterial and central venous pressures, urine output, systemic oxygen saturation and venous lactate concentration, as reported in the current recommendations [8] . Pump speed was adjusted in order to keep the cardiac index within Abiomed Inc., Aachen, Germany) was considered. The oxygenator and the circuit were replaced in case of clot formation within the system or major haemolysis. Whether IABP therapy was already in place at the time of E-CPR implantation, it was maintained until end of ECLS. Therapeutic hypothermia was performed by at least 24 hours (target: 34°C).
Weaning from ECLS was considered when partial or complete recovery from cardiac dysfunction could be demonstrated on echocardiography, associated with the presence of a stable pulsatile blood pressure waveform, and mean blood pressure remaining above 60 mmHg during a weaning trial (progressive reduction of the ECLS flow until a minimum of 1 l/min), while receiving minimal or low dose inotropic agents.
Definitions.
We defined refractory cardiac arrest as persisting beyond the 30 th minute of CPR.
Etiologies of cardiac arrest were categorized as follows: Cardiac disease (further divided into AMI, Cardiomyopathy, Acute myocarditis, Refractory arrhythmia, Acute pulmonary embolism), Respiratory disease, Trauma (including hypothermia, suicide attempt, drug overdose), Sepsis, and Miscellaneous (those cases which could not be categorized into the other groups). Vascular complications at the site of E-CPR implantation were the need to perform at least one additional surgical procedure to revise hemostasis at the site of cannulation for ECLS, or to reconstruct/repair the involved vessels. Lower limb ischemia was the need to perform at least one additional surgical procedure to relief ischemia and/or treat compartmental syndrome. Hemorrhagic complications on ECLS were the M A N U S C R I P T . Brain death of patients on ECLS had to be declared by at least two intensive care medicine specialists in consensus according to the criteria fixed by the French law (abolition of all brainstem reflexes, absence of spontaneous ventilation at hypercapnia test -P CO2 >60 mmHg, and two electroencephalography recordings practiced with a 4-hours interval).
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Patients were evaluated using the SAPS score (version 2) at the time of E-CPR implantation [9] , using the calculator available online at www.sfar.org (website of the French Society of Anesthesia and Intensive Care).
Follow-up and Quality-of-Life assessment.
A follow-up program for patients receiving ECLS at our Institution was started in April 2013. Patients who were alive at the time of hospital discharge were contacted telephonically by research nurses experienced in the chronic management of patients receiving surgical treatment for heart failure. All patients could be contacted and Health Survey, SF-36) [10, 11, 12] . The questionnaire was administered according to recommendations [10] , and provided a score for each of the following domains: physical activity, role limitation, physical pain, general health, vitality, social activity, mental health,
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physical component summary and mental component summary. The SF-36 questionnaire has been previously employed in the evaluation of health-related quality-of-life in patients surviving critical illness thanks to ECLS [13] , veno-venous extracorporeal membrane oxygenation [14] , and in patients with advanced heart failure [15, 16, 17] . The SF-36 has been also employed to evaluate survivors to cardiac arrest who have not been treated by E-CPR [17] . Data were entered into the Rennes ECLS Registry.
Management of data and statistical analysis.
Since the beginning of the ECLS program at our Institution, the clinical data pertaining to each patient receiving such treatment are prospectively entered in an electronic database.
This includes all pre-and post-implantation data, major biological and hemodynamic parameters, drug therapy and in-hospital complications. The database is regularly checked Continuous data are presented as mean ± standard deviation, and categorical variables as percentages. Intergroup comparison was performed using the two-tailed Student's t test for continuous data, and the chi-square test for categorical data. All available baseline variables were used for intergroup comparison (about forty variables). Survival analysis was conducted according the Kaplan-Meier methodology, and the corresponding survival curves were built. Analyses were performed using the SAS software ver. 9.33 for Windows (SAS Institute Inc., Cary, NC).
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Results
The study workflow is reported in Figure 1 . Forty-nine patients received E-CPR (18.1% of overall ECLS activity at our Institution). The baseline features of the study population and the indications to E-CPR treatment are summarized in Table 1 . Most frequently, the indication to E-CPR pertained to the Cardiac disease group; among these, AMI was prevailing (47% of the 30 patients pertaining to such group). Two patients had baseline respiratory disease, which led to anoxic refractory cardiac arrest and required E-CPR. In Higher SAPS score, lower body temperature and higher lactate level at the time of ECLS implantation were statistically associated with death before explantation. Table 3 compares the rates of bridge to urgent heart transplantation or to LVAD among patients who received E-CPR vs. the remaining patients who received veno-arterial ECLS in our Institution during the same time period.
Late Results.
The follow-up was 94.5% complete (one patient was lost); its average duration was 15. Globally, our patients showed lower average SF-36 scores than control patients, but they had also better performance than the comparator ECMO/ECLS cohorts.
Comment
Since the earliest experiences about E-CPR to rescue refractory cardiac arrest, 30-days survival in this complex patients subgroup raised from 24% [12, 19] to about 34% in recent times [20] and to 39% in selected populations (MI-related cardiac arrest [1] ). Such tendency is confirmed herein. We observed a 42.9% survival at ECLS explantation and a 36.7% survival at both 30 days and hospital discharge. Our series should be compared with previously published experiences which included only patients who received ECLS during ongoing CPR. Otherwise, the interpretation of previously reported survival rates up to 50% [5] may be misleading. Yet, ECLS guarantees a survival advantage over conventional CPR if this protracts beyond 10 minutes [21] . Such amelioration may be ascribed to improved selection of candidates and growing experience of E-CPR teams.
Prompt decision-making and effective organization are crucial to achieve survival of these M A N U S C R I P T
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critically ill patients. In fact, anoxic brain death of patients treated with E-CPR appeared to be one major threaten in the published experiences [6, 23] .
Causes of death on ECLS support are closely related to the major decision-making issues encountered in these patients. Despite the relatively low rate of out-of-hospital cardiac arrest in our series (12%), the rate of brain death among the E-CPR recipients remains remarkable (24.5% overall). Conversely, multiorgan failure is the most prevalent cause of death in our population: end-organ damage induced by cardiogenic shock can be reasonably considered as the triggering factor for this ominous condition. Such concept underlines the importance of prompt and effective CPR and institution of E-CPR.
Concordantly, in our study survivors presented a trend towards significantly shorter average low-flow time and, additionally, absence of no-flow time. Nonetheless, ECLS itself represents a trigger for systemic inflammatory reaction: it has been associated with a 'cytokine storm' (Tumor Necrosis Factor-alpha, TNF-α, Interleukin 8, IL-8, IL-6) which may propagate organ injury [23] . Evidence from the animal model suggests that such mechanism may also play a role in delayed pulmonary recovery during veno-venous ECLS for severe respiratory failure [24] . Interestingly, myocardial failure itself is the less common determinant of the final outcome once ECLS has been instituted. Fatal issue due to failed electrical recovery from cardiac arrest was observed in 2 cases in our series despite effective ventricular unloading. Early termination of support was decided in these cases.
Patients who present failed recovery of myocardial contractility over the later days may be bridged to urgent heart transplantation or to destination LVAD (2 cases each in our series, 9.5% of the survivors at the 30 th day). Nonetheless, rational employment of transplantation and VAD resources restrain their use to patients with survivable levels of end-organ dysfunction. It has been proposed that recovery from the initial shock-related injury should be expected within the 2 nd -5 th postimplantation day; ECLS-related end-organ injury would M A N U S C R I P T
become clinically significant in the later days and render end-organ recovery unlikely [25] .
Non-surviving patients presented higher SAPS score, lower body temperature and higher serum lactates at implantation compared to survivors. We observed also a trend towards longer low-flow time among non-survivors. Lower blood pH was observed among nonsurvivors, although significance was not attained. These data should be interpreted cautiously, since no multivariate analysis could be performed. Nonetheless, these observations suggest the importance of the degree of end-organ injury in the determinism of survival and may support the decision-making.
In light of worse results, there is controversy over the opportunity of employing E-CPR outside the referral Institution for out-of-hospital cardiac arrest [1, 26, 27] . Not only clinical factors, but also organizational, public healthcare, economic and ethical issues are expertise, the non-negligible learning curve and the major social costs support the reservation of this technique to tertiary centers. The concept of territorial network (several peripheral hospitals depending on one tertiary center) is part of this debate. As ECLS is at the frontier between cardiology, cardiac surgery and intensive care medicine, professionals involved in all these specialties are expected to contribute and develop shared recommendations.
Interestingly, it emerged from our experience that the rate of bridge to heart transplantation is comparable among patients receiving E-CPR vs. the remainder veno-arterial ECLS M A N U S C R I P T
cases at our Institution (Table 3 ). The rate of long-term VAD implantation was even higher among refractory cardiac arrest patients. Such analysis is limited by low sample size and should be interpreted keeping in mind the heterogeneous composition of the non-cardiac arrest population (including patients receiving ECLS for early graft failure and postcardiotomy myocardial failure) and the different average age (younger among the E-CPR patients). Nevertheless, this information suggests that urgent transplantation and longterm VAD are as effective among rescued-cardiac arrest individuals as in the general ECLS population. Therefore, the E-CPR patients should be submitted to the same decisional criteria than conventional ECLS patients, although particular attention must be devoted to the assessment of brain death and nonsurvivable end-organ injury.
One major finding of the present work consists in the demonstration of stable survival at the mid-term follow-up among patients who were discharged from the hospital. Concerning the assessment of quality-of-life, better scores were observed for Mental Health and related domains; lower scores were observed for the General Health and Vitality domains.
This may be interpreted as the consequences at the early-to mid-term follow-up of longterm hospitalization and ICU stay. The subtending disease, ICU-related neuropathy, hyponutrition and the high rate of complications may explain such finding. It is reasonable to expect improvements in these domains and more complete recovery at later intervals.
Survivors to cardiac arrest using E-CPR showed herein worse health-related quality-of-life scores than the normal matched French population, as the expression of severe disease and prolonged hospitalization. Interestingly, our E-CPR patients presented better average scores in all SF-36 domains compared to previous studies over ECLS patients [13] , venovenous ECMO patients of the CESAR study [14] and survivors to post-cardiotomy myocardial failure through ECLS [13] (Figure 3 ). Such finding may be attributed to different characteristics of the comparator populations. Namely, patients on veno-venous ECMO are particularly likely to experience particularly long and debilitating hospitalization in M A N U S C R I P T
critical care environment. The patients enrolled in the study by Wang and associates all presented post-cardiotomy myocardial failure and structural heart disease, with inherent negative prognostic significance [13] . Collectively, our data suggest that survivors to acute events thanks to E-CPR may attain satisfactory health-related quality-of-life compared to similar populations of critical care patients. Similarly, the SF-36 Mental and Physical summary scores were comparable to those obtained among survivors to cardiac arrest without E-CPR treatment [18] . The present paper reports for the first time measures of quality-of-life among patients surviving refractory cardiac arrest thanks to E-CPR.
Therefore, the practice of E-CPR is justified by the possibility to achieve good functional results in the survivors.
The present investigation is limited by retrospective analysis of data; such limitation is partially offset by the prospective inclusion of patients' information into a dedicated database. Another limitation is the lack of a control group (survivors to cardiac arrest who did not receive E-CPR). On the other hand, we limited the inclusion to patients who received E-CPR during ongoing external cardiac massage. This allows focusing on a more selected population than previous reports [5] . As a further minor limitation, the rate of thromboembolic and hemorrhagic complications is given in aggregate form.
Conclusions.
Use of E-CPR is an effective strategy which allows saving lives in a population of severely compromised patients. This is probably the most challenging domain within an ECLS
program. The survival at ECLS explantation reported herein is among the highest published so far. Patients who survive the initial cardiac arrest injury thanks to E-CPR may subsequently enter the same decision-making algorithm than patients who received ECLS M A N U S C R I P T
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during non-cardiac arrest circumstances. Nonetheless, high rates of brain death and nonsurvivable end-organ injury are common among patients rescued from cardiac arrest, and may preclude bridging to urgent transplantation or VAD in a significant proportion of cases.
Overall, about one third of patients in our experience survived at both discharge and midterm follow-up. Remarkably, survival tends to remain stable after discharge. Health-related quality-of-life among survivors is better or comparable than in previous investigations over ECLS / ECMO recipients or cardiac arrest survivors. These findings support the practice of E-CPR, provided that adequate patients' selection is performed in order to avoid unjustified employment of hospital resources.
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Survival curve for patients receiving E-CPR (follow-up: 15.6 ± 19.2 months). 
